Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Randomized Study of Early Palliative Care Integrated With Standard Oncology Care Versus Standard Oncology Care Alone in Patients With Incurable Lung or Non-Colorectal Gastrointestinal Malignancies
Status: Enrolling
Updated:  12/31/1969
Mercy Health Saint Mary's
mi
from
Grand Rapids, MI
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Randomized Study of Early Palliative Care Integrated With Standard Oncology Care Versus Standard Oncology Care Alone in Patients With Incurable Lung or Non-Colorectal Gastrointestinal Malignancies
Status: Enrolling
Updated: 12/31/1969
Mercy Health Saint Mary's
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Randomized Study of Early Palliative Care Integrated With Standard Oncology Care Versus Standard Oncology Care Alone in Patients With Incurable Lung or Non-Colorectal Gastrointestinal Malignancies
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Randomized Study of Early Palliative Care Integrated With Standard Oncology Care Versus Standard Oncology Care Alone in Patients With Incurable Lung or Non-Colorectal Gastrointestinal Malignancies
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Randomized Study of Early Palliative Care Integrated With Standard Oncology Care Versus Standard Oncology Care Alone in Patients With Incurable Lung or Non-Colorectal Gastrointestinal Malignancies
Status: Enrolling
Updated:  12/31/1969
Columbia University Herbert Irving Cancer Center
mi
from
New York, NY
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Randomized Study of Early Palliative Care Integrated With Standard Oncology Care Versus Standard Oncology Care Alone in Patients With Incurable Lung or Non-Colorectal Gastrointestinal Malignancies
Status: Enrolling
Updated: 12/31/1969
Columbia University Herbert Irving Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Randomized Study of Early Palliative Care Integrated With Standard Oncology Care Versus Standard Oncology Care Alone in Patients With Incurable Lung or Non-Colorectal Gastrointestinal Malignancies
Status: Enrolling
Updated:  12/31/1969
Gundersen Lutheran Medical Center
mi
from
La Crosse, WI
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Randomized Study of Early Palliative Care Integrated With Standard Oncology Care Versus Standard Oncology Care Alone in Patients With Incurable Lung or Non-Colorectal Gastrointestinal Malignancies
Status: Enrolling
Updated: 12/31/1969
Gundersen Lutheran Medical Center
mi
from
La Crosse, WI
Click here to add this to my saved trials
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Randomized Study of Early Palliative Care Integrated With Standard Oncology Care Versus Standard Oncology Care Alone in Patients With Incurable Lung or Non-Colorectal Gastrointestinal Malignancies
Status: Enrolling
Updated:  12/31/1969
Marshfield Clinic
mi
from
Marshfield, WI
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Randomized Study of Early Palliative Care Integrated With Standard Oncology Care Versus Standard Oncology Care Alone in Patients With Incurable Lung or Non-Colorectal Gastrointestinal Malignancies
Status: Enrolling
Updated: 12/31/1969
Marshfield Clinic
mi
from
Marshfield, WI
Click here to add this to my saved trials
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
New Haven, CT
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Miami, FL
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Marietta, GA
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Marietta, GA
Click here to add this to my saved trials
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Iowa City, IA
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Wichita, KA
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Wichita, KA
Click here to add this to my saved trials
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Baltimore, MD
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Watertown, MA
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Watertown, MA
Click here to add this to my saved trials
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Cedarhurst, NY
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cedarhurst, NY
Click here to add this to my saved trials
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
New York, NY
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Staten Island, NY
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Staten Island, NY
Click here to add this to my saved trials
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Cincinnati, OH
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Allentown, PA
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Allentown, PA
Click here to add this to my saved trials
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Charleston, SC
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Wichita Falls, TX
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Wichita Falls, TX
Click here to add this to my saved trials
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Richland, WA
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Richland, WA
Click here to add this to my saved trials
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated:  12/31/1969
mi
from
Banfield,
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
Status: Enrolling
Updated: 12/31/1969
mi
from
Banfield,
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects With Major Depressive Disorder With Anxious Distress
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Costa Mesa, CA
An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects With Major Depressive Disorder With Anxious Distress
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects With Major Depressive Disorder With Anxious Distress
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Oceanside, CA
An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects With Major Depressive Disorder With Anxious Distress
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects With Major Depressive Disorder With Anxious Distress
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Miami, FL
An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects With Major Depressive Disorder With Anxious Distress
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects With Major Depressive Disorder With Anxious Distress
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Natick, MA
An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects With Major Depressive Disorder With Anxious Distress
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Natick, MA
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects With Major Depressive Disorder With Anxious Distress
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Cedarhurst, NY
An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects With Major Depressive Disorder With Anxious Distress
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cedarhurst, NY
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects With Major Depressive Disorder With Anxious Distress
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Raleigh, NC
An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects With Major Depressive Disorder With Anxious Distress
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects With Major Depressive Disorder With Anxious Distress
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Allentown, PA
An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects With Major Depressive Disorder With Anxious Distress
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Allentown, PA
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects With Major Depressive Disorder With Anxious Distress
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects With Major Depressive Disorder With Anxious Distress
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects With Major Depressive Disorder With Anxious Distress
Status: Enrolling
Updated:  12/31/1969
mi
from
Chisinau,
An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects With Major Depressive Disorder With Anxious Distress
Status: Enrolling
Updated: 12/31/1969
mi
from
Chisinau,
Click here to add this to my saved trials
Telephone-Based Counseling for Depression in Parkinson's Disease
Improving Access to Depression Care in Parkinson's Disease: A Telehealth Approach
Status: Enrolling
Updated:  12/31/1969
Rutgers University-Robert Wood Johnson Medical School
mi
from
Piscataway, NJ
Telephone-Based Counseling for Depression in Parkinson's Disease
Improving Access to Depression Care in Parkinson's Disease: A Telehealth Approach
Status: Enrolling
Updated: 12/31/1969
Rutgers University-Robert Wood Johnson Medical School
mi
from
Piscataway, NJ
Click here to add this to my saved trials
Mindfulness Intervention in Reducing Anxiety in Patients Who Have Been Treated for Gynecologic Cancer
Mindfulness-Based Interventions in Patients Treated for Gynecologic Cancer - Impact on Patient Reported Outcomes and Immunologic Correlates
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin Carbone Cancer Center
mi
from
Madison, WI
Mindfulness Intervention in Reducing Anxiety in Patients Who Have Been Treated for Gynecologic Cancer
Mindfulness-Based Interventions in Patients Treated for Gynecologic Cancer - Impact on Patient Reported Outcomes and Immunologic Correlates
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin Carbone Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Building Community Capacity for Disability Prevention for Minority Elders (Positive Minds - Strong Bodies)
Building Community Capacity for Disability Prevention for Minority Elders
Status: Enrolling
Updated:  12/31/1969
Greater Boston Chinese Golden Age Center
mi
from
Boston, MA
Building Community Capacity for Disability Prevention for Minority Elders (Positive Minds - Strong Bodies)
Building Community Capacity for Disability Prevention for Minority Elders
Status: Enrolling
Updated: 12/31/1969
Greater Boston Chinese Golden Age Center
mi
from
Boston, MA
Click here to add this to my saved trials
Building Community Capacity for Disability Prevention for Minority Elders (Positive Minds - Strong Bodies)
Building Community Capacity for Disability Prevention for Minority Elders
Status: Enrolling
Updated:  12/31/1969
Kit Clark Senior Services
mi
from
Dorchester, MA
Building Community Capacity for Disability Prevention for Minority Elders (Positive Minds - Strong Bodies)
Building Community Capacity for Disability Prevention for Minority Elders
Status: Enrolling
Updated: 12/31/1969
Kit Clark Senior Services
mi
from
Dorchester, MA
Click here to add this to my saved trials
Building Community Capacity for Disability Prevention for Minority Elders (Positive Minds - Strong Bodies)
Building Community Capacity for Disability Prevention for Minority Elders
Status: Enrolling
Updated:  12/31/1969
Central Harlem Senior Citizens' Center
mi
from
New York, NY
Building Community Capacity for Disability Prevention for Minority Elders (Positive Minds - Strong Bodies)
Building Community Capacity for Disability Prevention for Minority Elders
Status: Enrolling
Updated: 12/31/1969
Central Harlem Senior Citizens' Center
mi
from
New York, NY
Click here to add this to my saved trials
Building Community Capacity for Disability Prevention for Minority Elders (Positive Minds - Strong Bodies)
Building Community Capacity for Disability Prevention for Minority Elders
Status: Enrolling
Updated:  12/31/1969
Hamilton Madison City Hall Senior Center
mi
from
New York, NY
Building Community Capacity for Disability Prevention for Minority Elders (Positive Minds - Strong Bodies)
Building Community Capacity for Disability Prevention for Minority Elders
Status: Enrolling
Updated: 12/31/1969
Hamilton Madison City Hall Senior Center
mi
from
New York, NY
Click here to add this to my saved trials
Building Community Capacity for Disability Prevention for Minority Elders (Positive Minds - Strong Bodies)
Building Community Capacity for Disability Prevention for Minority Elders
Status: Enrolling
Updated:  12/31/1969
King David Foundation
mi
from
Aventura, FL
Building Community Capacity for Disability Prevention for Minority Elders (Positive Minds - Strong Bodies)
Building Community Capacity for Disability Prevention for Minority Elders
Status: Enrolling
Updated: 12/31/1969
King David Foundation
mi
from
Aventura, FL
Click here to add this to my saved trials
Building Community Capacity for Disability Prevention for Minority Elders (Positive Minds - Strong Bodies)
Building Community Capacity for Disability Prevention for Minority Elders
Status: Enrolling
Updated:  12/31/1969
MGH Chelsea
mi
from
Chelsea, MA
Building Community Capacity for Disability Prevention for Minority Elders (Positive Minds - Strong Bodies)
Building Community Capacity for Disability Prevention for Minority Elders
Status: Enrolling
Updated: 12/31/1969
MGH Chelsea
mi
from
Chelsea, MA
Click here to add this to my saved trials
Building Community Capacity for Disability Prevention for Minority Elders (Positive Minds - Strong Bodies)
Building Community Capacity for Disability Prevention for Minority Elders
Status: Enrolling
Updated:  12/31/1969
MGH Revere
mi
from
Revere, MA
Building Community Capacity for Disability Prevention for Minority Elders (Positive Minds - Strong Bodies)
Building Community Capacity for Disability Prevention for Minority Elders
Status: Enrolling
Updated: 12/31/1969
MGH Revere
mi
from
Revere, MA
Click here to add this to my saved trials
Building Community Capacity for Disability Prevention for Minority Elders (Positive Minds - Strong Bodies)
Building Community Capacity for Disability Prevention for Minority Elders
Status: Enrolling
Updated:  12/31/1969
Univ of Puerto Rico
mi
from
San Juan,
Building Community Capacity for Disability Prevention for Minority Elders (Positive Minds - Strong Bodies)
Building Community Capacity for Disability Prevention for Minority Elders
Status: Enrolling
Updated: 12/31/1969
Univ of Puerto Rico
mi
from
San Juan,
Click here to add this to my saved trials
Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Personalized Approach
Omega-3 Fatty Acids for MDD With High Inflammation: A Personalized Approach
Status: Enrolling
Updated:  12/31/1969
Emory University School of Medicine
mi
from
Atlanta, GA
Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Personalized Approach
Omega-3 Fatty Acids for MDD With High Inflammation: A Personalized Approach
Status: Enrolling
Updated: 12/31/1969
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Personalized Approach
Omega-3 Fatty Acids for MDD With High Inflammation: A Personalized Approach
Status: Enrolling
Updated:  12/31/1969
The Depression Clinical and Research Program, Massachusetts General Hospital
mi
from
Boston, MA
Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Personalized Approach
Omega-3 Fatty Acids for MDD With High Inflammation: A Personalized Approach
Status: Enrolling
Updated: 12/31/1969
The Depression Clinical and Research Program, Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Noninvasive Physiologic Sensors to Assess Depression
Non-Invasive Physiologic Sensors to Assess Depression
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Noninvasive Physiologic Sensors to Assess Depression
Non-Invasive Physiologic Sensors to Assess Depression
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Ketamine Infusion for Adolescent Depression and Anxiety
Efficacy of Rapid-Acting NMDA Antagonist for Treatment of Adolescent Depression and Anxiety Disorders
Status: Enrolling
Updated:  12/31/1969
Hospital Research Unit at the Yale New Haven Hospital
mi
from
New Haven, CT
Ketamine Infusion for Adolescent Depression and Anxiety
Efficacy of Rapid-Acting NMDA Antagonist for Treatment of Adolescent Depression and Anxiety Disorders
Status: Enrolling
Updated: 12/31/1969
Hospital Research Unit at the Yale New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Ketamine Infusion for Adolescent Depression and Anxiety
Efficacy of Rapid-Acting NMDA Antagonist for Treatment of Adolescent Depression and Anxiety Disorders
Status: Enrolling
Updated:  12/31/1969
Yale Child Study Center
mi
from
New Haven, CT
Ketamine Infusion for Adolescent Depression and Anxiety
Efficacy of Rapid-Acting NMDA Antagonist for Treatment of Adolescent Depression and Anxiety Disorders
Status: Enrolling
Updated: 12/31/1969
Yale Child Study Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Predictors of Depression Treatment Response to Exercise
Predictors of Depression Treatment Response to Exercise
Status: Enrolling
Updated:  12/31/1969
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Predictors of Depression Treatment Response to Exercise
Predictors of Depression Treatment Response to Exercise
Status: Enrolling
Updated: 12/31/1969
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Using CBT to Probe Psychobiobehavioral Resilience to Post-trauma Psychopathology
Using CBT to Probe Psychobiobehavioral Resilience to Post-trauma Psychopathology
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Using CBT to Probe Psychobiobehavioral Resilience to Post-trauma Psychopathology
Using CBT to Probe Psychobiobehavioral Resilience to Post-trauma Psychopathology
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
The Use of Duloxetine for Cognition Improvement in Individuals With Mild Cognitive Impairment
The Depression and Memory Trial
Status: Enrolling
Updated:  12/31/1969
University of North Texas Health Science Center
mi
from
Fort Worth, TX
The Use of Duloxetine for Cognition Improvement in Individuals With Mild Cognitive Impairment
The Depression and Memory Trial
Status: Enrolling
Updated: 12/31/1969
University of North Texas Health Science Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Status: Enrolling
Updated:  12/31/1969
Ambulatory Research Center (ARC)
mi
from
Minneapolis, MN
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
Status: Enrolling
Updated: 12/31/1969
Ambulatory Research Center (ARC)
mi
from
Minneapolis, MN
Click here to add this to my saved trials